🏛️ Verified NIH Record • Updated 2026-08-11
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis (NCT07265479)
A Randomized, Double-Blind, Vehicle-Controlled (Period 1) and Open-Label (Period 2) Phase 3 Study to Investigate the Safety and Efficacy of Tapinarof Cream, 1% in Pediatric Participants Ages 3 Months to < 24 Months With Atopic Dermatitis
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic Sponsor: Organon and Co
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this global Phase 3 clinical study is to investigate the safety and efficacy of tapinarof cream, 1% in participants ages 3 months to 23 months (inclusive) with atopic dermatitis.
Who can join: Review the eligibility criteria below.
Location: AllerVie Clinical Research — Birmingham, Alabama
Age range: 3 Months to 23 Months
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (46 Sites)
Showing the first 25 of 46 sites.
- AllerVie Clinical Research — Birmingham, Alabama
- Dermatology Trial Associates — Bryant, Arkansas
- Dermatology Research Associates — Los Angeles, California
- Integrative Skin Science and Research — Sacramento, California
- Allergy and Asthma Medical Group and Research Center — San Diego, California
- Clinical Trials Research Institute — Thousand Oaks, California
- Clarity Dermatology — Castle Rock, Colorado
- Skin Care Research, LLC. — Boca Raton, Florida
- APEX Clinical Trials — Jacksonville, Florida
- TruDerm Research — Wellington, Florida
- Cleaver Medical Group Dermatology, Inc — Cumming, Georgia
- Ada West Research — Meridian, Idaho
- Endeavor Health Clinical Trials Center — Skokie, Illinois
- Dawes Fretzin Clinical Research Group, LLC — Indianapolis, Indiana
- The Indiana Clinical Trials Center, PC — Plainfield, Indiana
- Equity Medical, LLC — Bowling Green, Kentucky
- Lawrence J Green, MD LLC — Rockville, Maryland
- Oakland Hills Dermatology — Auburn Hills, Michigan
- Minnesota Clinical Study Center — New Brighton, Minnesota
- SKY Integrative Medical Center — Ridgeland, Mississippi
- MediSearch Clinical Trials — Saint Joseph, Missouri
- Skin Cancer and Dermatology Institute — Reno, Nevada
- Forest Hills Dermatology Group — Kew Gardens, New York
- Bobby Buka MD, PC — New York, New York
- Equity Medical, LLC — The Bronx, New York
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Atopic Dermatitis
- A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden — Birmingham, Alabama
- ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis — Phoenix, Arizona
- A Study of Barzolvolimab in Patients With Atopic Dermatitis — Birmingham, Alabama
- Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis — Chicago, Illinois
- A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis — Birmingham, Alabama
- A Study Evaluating APG777 in Atopic Dermatitis — Fountain Valley, California
Explore by condition: All Atopic Dermatitis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.